Latest Videos |view all videos
Robert D. Simari, M.D., Vice Chair of Mayo Clinic's Department of Cardiovascular Diseases discusses this year's American College of Cardiology Meeting (ACC)
Randal J. Thomas, M.D., director of Mayo Clinic's Cardiovascular Health Clinic, and colleagues found that patients who participate in cardiac rehabilitation after having heart interventions have a 45 percent lower mortality rate.
Mayo Clinic researchers have found that cardiac patients who have skin allergies to metals commonly found in jewelry, such as nickel, are at no higher risk for complications if they receive a stent containing these metal components.
A recent study co-authored by Mayo Clinic physicians and presented at the 2012 ACC Annual Scientific Session & Expo might change the way we assess obesity in individuals with heart disease.
Thom W. Rooke, M.D., a professor of medicine at Mayo Clinic's Gonda Vascular Center, provides information about fibromuscular dysplasia (FMD). Dr. Rooke highlights what FMD is, the problems it causes, treatments and resources available ...
Roger D. White, M.D., discusses his article of a case of out-of-hospital cardiac arrest with 96 minutes of continued pulselessness and relentless ventricular defibrillation.
Cardiologist Stephen Kopecky, M.D., discusses genetic testing that may allow physicians to predict the drugs and dosages most effective for patients with high cholesterol.
Body size, gender and the complexity of heart disease significantly influence how much cumulative radiation skin dose that patients receive during percutaneous coronary intervention (PCI) therapy, also known as angioplasty.
Thomas Moyer, Ph.D., from Mayo Clinic's Department of Laboratory Medicine and Pathology, offers background on the blood-thinner warfarin and why genetic variations in patients affect the dose that will be needed.